Clinical Trial Update: Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intrathecal administration of a PD-1 antibody for leptomeningeal metastasis from metastatic solid tumors. The study is sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis

Drugs mentioned

• PD-1 antibody (intrathecal)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Leptomeningeal Disease | Phase 1 | Status: RECRUITING